Philippines - anglais - FDA (Food And Drug Administration)

west wing pharma sales inc - salbutamol (as sulfate) , guaifenesine - syrup - 1mg + 50mg per 5ml

Philippines - anglais - FDA (Food And Drug Administration)

west wing pharma sales, inc.; distributor: rsg mktg. corp. - tranexamic acid - solution for injection (im/iv) - 500mg/ 5ml

Philippines - anglais - FDA (Food And Drug Administration)

west wing pharma sales, inc.; distributor: seahorse industries inc. - tranexamic acid - solution for injection (im/iv) - 500mg/ 5ml

Philippines - anglais - FDA (Food And Drug Administration)

west wing pharma sales inc. - vitamin b-complex - solution for injection im/iv

Philippines - anglais - FDA (Food And Drug Administration)

west wing pharma sales inc.; distributor: euro-care products phils - cetirizine dihydrochloride - syrup - 5mg/5ml

Philippines - anglais - FDA (Food And Drug Administration)

west wing pharma sales inc.; distributor: euro-care products phils - tranexamic acid - solution for injection. (im/iv) - 500mg/5ml

Philippines - anglais - FDA (Food And Drug Administration)

west wing pharma sales inc.; distributor: euro-care products phils - diclofenac (as sodium) - solution for injection (im/iv) - 25mg/ml (75mg/3ml)

Philippines - anglais - FDA (Food And Drug Administration)

west wing pharma sales inc. - doxycycline (as hyclate) - capsule - 100 mg

États-Unis - anglais - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - amlodipine 2.5 mg - amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic

Israël - anglais - Ministry of Health

medison pharma ltd - mecasermin - solution for injection - mecasermin 10 mg / 1 ml - mecasermin - for the long-term treatment of growth failure in children and adolescents from 2 to 18 years with confirmed severe primary insulin-like growth factor-1 deficiency (primary igfd).severe primary igfd is defined by:* height standard deviation score ≤–3.0and* basal igf-1 levels below the 2.5th percentile for age and genderand* gh sufficiency.* exclusion of secondary forms of igf-1 deficiency, such as malnutrition, hypothyroidism, or chronic treatment with pharmacologic doses of anti-inflammatory steroids.severe primary igfd includes patients with mutations in the gh receptor (ghr), post-ghr signaling pathway, and igf-1 gene defects; they are not gh deficient, and therefore, they cannot be expected to respond adequately to exogenous gh treatment.in some cases, when deemed necessary, the physician may decide to assist in the diagnosis by performing an igf-i generation test.